CHD2-Related CNS Pathologies
- PMID: 33435571
- PMCID: PMC7827033
- DOI: 10.3390/ijms22020588
CHD2-Related CNS Pathologies
Abstract
Epileptic encephalopathies (EE) are severe epilepsy syndromes characterized by multiple seizure types, developmental delay and even regression. This class of disorders are increasingly being identified as resulting from de novo genetic mutations including many identified mutations in the family of chromodomain helicase DNA binding (CHD) proteins. In particular, several de novo pathogenic mutations have been identified in the gene encoding chromodomain helicase DNA binding protein 2 (CHD2), a member of the sucrose nonfermenting (SNF-2) protein family of epigenetic regulators. These mutations in the CHD2 gene are causative of early onset epileptic encephalopathy, abnormal brain function, and intellectual disability. Our understanding of the mechanisms by which modification or loss of CHD2 cause this condition remains poorly understood. Here, we review what is known and still to be elucidated as regards the structure and function of CHD2 and how its dysregulation leads to a highly variable range of phenotypic presentations.
Keywords: CHD2; developmental epileptic encephalopathy; epigenetics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures.Epilepsy Behav. 2015 Oct;51:53-6. doi: 10.1016/j.yebeh.2015.06.029. Epub 2015 Aug 7. Epilepsy Behav. 2015. PMID: 26262932
-
De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.Am J Hum Genet. 2013 Nov 7;93(5):967-75. doi: 10.1016/j.ajhg.2013.09.017. Epub 2013 Oct 24. Am J Hum Genet. 2013. PMID: 24207121 Free PMC article.
-
Novel Loss-of-Function Variants in CHD2 Cause Childhood-Onset Epileptic Encephalopathy in Chinese Patients.Genes (Basel). 2022 May 19;13(5):908. doi: 10.3390/genes13050908. Genes (Basel). 2022. PMID: 35627293 Free PMC article.
-
Chromatin Remodeling Proteins in Epilepsy: Lessons From CHD2-Associated Epilepsy.Front Mol Neurosci. 2018 Jun 15;11:208. doi: 10.3389/fnmol.2018.00208. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29962935 Free PMC article. Review.
-
A roadmap to cure CHD2-related disorders.Ther Adv Rare Dis. 2024 Oct 8;5:26330040241283749. doi: 10.1177/26330040241283749. eCollection 2024 Jan-Dec. Ther Adv Rare Dis. 2024. PMID: 39391213 Free PMC article. Review.
Cited by
-
Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance.Genome Med. 2021 Oct 19;13(1):162. doi: 10.1186/s13073-021-00980-1. Genome Med. 2021. PMID: 34663447 Free PMC article.
-
Expanding the Mutational Landscape and Clinical Phenotype of CHD2-Related Encephalopathy.Neurol Genet. 2024 Jul 11;10(4):e200168. doi: 10.1212/NXG.0000000000200168. eCollection 2024 Aug. Neurol Genet. 2024. PMID: 39035822 Free PMC article.
-
Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes.Front Neurol. 2022 Mar 11;13:832380. doi: 10.3389/fneur.2022.832380. eCollection 2022. Front Neurol. 2022. PMID: 35359639 Free PMC article.
-
Candidate Genes for Eyelid Myoclonia with Absences, Review of the Literature.Int J Mol Sci. 2021 May 25;22(11):5609. doi: 10.3390/ijms22115609. Int J Mol Sci. 2021. PMID: 34070602 Free PMC article. Review.
-
Mammalian Resilience Revealed by a Comparison of Human Diseases and Mouse Models Associated With DNA Helicase Deficiencies.Front Mol Biosci. 2022 Aug 11;9:934042. doi: 10.3389/fmolb.2022.934042. eCollection 2022. Front Mol Biosci. 2022. PMID: 36032672 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources